Fox Chase and Weill Cornell Medicine selected as founding members of NCI prevention initiative

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Fox Chase Cancer Center and Weill Cornell Medicine were selected to develop a new Cancer Prevention-Interception Targeted Agent Discovery Program. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Login